Concerns have been raised about potential conflicts of interest in medical publishing related to pharmaceutical advertising and industry funding. Several analyses have examined whether financial relationships influence the types of research that appear in medical journals.
A study published in BMC Complementary and Alternative Medicine (April 9, 2008; 8:11) evaluated the relationship between pharmaceutical advertising volume and journal content related to nutritional supplements. The authors compared the amount of drug company advertising in individual journals with the number and tone of articles addressing dietary supplements. Journals that carried higher levels of pharmaceutical advertising published fewer articles on nutritional supplements, and when such articles appeared, they were more likely to present supplements in a negative context.
Concerns about editorial independence have also been voiced by senior figures within medical publishing. Richard Smith, former editor of the British Medical Journal, publicly criticized the journal’s reliance on advertising revenue, stating that such dependence could compromise impartiality. He reported that approximately one-third of studies published in the BMJ were funded by the pharmaceutical industry.
Smith further estimated that two-thirds to three-quarters of clinical trials published in major medical journals—including the Annals of Internal Medicine, the Journal of the American Medical Association, the Lancet, and the New England Journal of Medicine—also receive pharmaceutical industry funding.
In addition to advertising revenue, journal income is influenced by reprint sales, which can be substantial. Pharmaceutical companies may spend hundreds of thousands to over one million dollars on bulk reprints of favorable trial results, providing another financial incentive tied to industry-sponsored research.
These findings have prompted ongoing discussion about the role of funding sources in shaping research agendas, editorial decisions, and the interpretation of scientific evidence in medical journals.
Click for link to a Washington Post article on this subject
